You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海南海藥(000566.SZ)擬將公司2019年度審計機構變更為大華
格隆匯 12-25 18:04

格隆匯12月25日丨海南海藥(000566.SZ)公佈,公司於2019年12月24召開了第九屆董事會第四十次會議,審議通過了《關於變更審計機構的議案》,擬將公司2019年度財務審計機構和內部控制審計機構變更為大華會計師事務所(特殊普通合夥)(“大華會計師事務所”)。

公司原審計機構立信會計師事務所(特殊普通合夥)(“立信會計師事務所”)在為公司提供審計服務期間勤勉盡責,始終堅持獨立審計的原則,客觀、公正、公允地反映了公司財務狀況,切實履行了審計機構職責。公司對立信會計師事務所在公司審計工作中表現出來的專業、盡責的工作精神表示誠摯的感謝!

鑑於公司控股股東、實際控制人擬發生變更,目前相關各方正在推進股權過户的相關手續;同時新興際華醫藥控股有限公司之股東新興際華集團有限公司的審計機構已變更為大華會計師事務所,審計工作將由大華會計師事務所承擔。為保證控制權變更後審計工作的協同性與一致性,公司擬聘請大華會計師事務所為公司2019年度財務審計及內部控制審計服務機構。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account